|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:IGF2R-ACVR2A (FusionGDB2 ID:38371) |
Fusion Gene Summary for IGF2R-ACVR2A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: IGF2R-ACVR2A | Fusion gene ID: 38371 | Hgene | Tgene | Gene symbol | IGF2R | ACVR2A | Gene ID | 3482 | 92 |
| Gene name | insulin like growth factor 2 receptor | activin A receptor type 2A | |
| Synonyms | CD222|CI-M6PR|CIMPR|M6P-R|M6P/IGF2R|MPR 300|MPR1|MPR300|MPRI | ACTRII|ACVR2 | |
| Cytomap | 6q25.3 | 2q22.3-q23.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | cation-independent mannose-6-phosphate receptor300 kDa mannose 6-phosphate receptorCI Man-6-P receptorIGF-II receptorM6P/IGF2 receptorinsulin-like growth factor II receptor | activin receptor type-2Aactivin A receptor, type IIA | |
| Modification date | 20200315 | 20200313 | |
| UniProtAcc | P11717 | P27037 | |
| Ensembl transtripts involved in fusion gene | ENST00000356956, ENST00000475584, | ENST00000535787, ENST00000241416, ENST00000404590, ENST00000495775, | |
| Fusion gene scores | * DoF score | 23 X 16 X 11=4048 | 5 X 6 X 5=150 |
| # samples | 25 | 6 | |
| ** MAII score | log2(25/4048*10)=-4.01720929003222 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/150*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: IGF2R [Title/Abstract] AND ACVR2A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | IGF2R(160390427)-ACVR2A(148672760), # samples:3 | ||
| Anticipated loss of major functional domain due to fusion event. | IGF2R-ACVR2A seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. IGF2R-ACVR2A seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. IGF2R-ACVR2A seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. IGF2R-ACVR2A seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ACVR2A | GO:0030509 | BMP signaling pathway | 18436533 |
| Tgene | ACVR2A | GO:0032927 | positive regulation of activin receptor signaling pathway | 12665502 |
| Tgene | ACVR2A | GO:0045648 | positive regulation of erythrocyte differentiation | 9032295 |
| Fusion gene breakpoints across IGF2R (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across ACVR2A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-BH-A0BL-01A | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| ChimerDB4 | BRCA | TCGA-BH-A0BL | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| ChimerDB4 | BRCA | TCGA-BH-A0BL-01A | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| ChimerDB4 | BRCA | TCGA-BH-A0BL-01A | IGF2R | chr6 | 160390427 | - | ACVR2A | chr2 | 148672760 | + |
Top |
Fusion Gene ORF analysis for IGF2R-ACVR2A |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000356956 | ENST00000535787 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| Frame-shift | ENST00000356956 | ENST00000241416 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| Frame-shift | ENST00000356956 | ENST00000404590 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| 5CDS-intron | ENST00000356956 | ENST00000495775 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| intron-3CDS | ENST00000475584 | ENST00000535787 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| intron-3CDS | ENST00000475584 | ENST00000241416 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| intron-3CDS | ENST00000475584 | ENST00000404590 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| intron-intron | ENST00000475584 | ENST00000495775 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672760 | + |
| Frame-shift | ENST00000356956 | ENST00000535787 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| Frame-shift | ENST00000356956 | ENST00000241416 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| Frame-shift | ENST00000356956 | ENST00000404590 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| 5CDS-intron | ENST00000356956 | ENST00000495775 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| intron-3CDS | ENST00000475584 | ENST00000535787 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| intron-3CDS | ENST00000475584 | ENST00000241416 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| intron-3CDS | ENST00000475584 | ENST00000404590 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| intron-intron | ENST00000475584 | ENST00000495775 | IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for IGF2R-ACVR2A |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + | 1.23E-05 | 0.9999877 |
| IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + | 1.23E-05 | 0.9999877 |
| IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + | 1.23E-05 | 0.9999877 |
| IGF2R | chr6 | 160390427 | + | ACVR2A | chr2 | 148672759 | + | 1.23E-05 | 0.9999877 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for IGF2R-ACVR2A |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| IGF2R | ACVR2A |
| FUNCTION: Mediates the transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes (PubMed:2963003, PubMed:18817523). Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex (PubMed:2963003, PubMed:18817523). The receptor is then recycled back to the Golgi for another round of trafficking through its binding to the retromer (PubMed:18817523). This receptor also binds IGF2 (PubMed:18046459). Acts as a positive regulator of T-cell coactivation by binding DPP4 (PubMed:10900005). {ECO:0000269|PubMed:10900005, ECO:0000269|PubMed:18046459, ECO:0000269|PubMed:18817523, ECO:0000269|PubMed:2963003}. | FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin A, activin B and inhibin A. Mediates induction of adipogenesis by GDF6 (By similarity). {ECO:0000250|UniProtKB:P27038, ECO:0000269|PubMed:1314589}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for IGF2R-ACVR2A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for IGF2R-ACVR2A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for IGF2R-ACVR2A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | IGF2R | P11717 | DB14751 | Mecasermin rinfabate | Biotech | Approved | |
| Hgene | IGF2R | P11717 | DB14751 | Mecasermin rinfabate | Biotech | Approved | |
| Hgene | IGF2R | P11717 | DB01277 | Mecasermin | Biotech | Approved|Investigational | |
| Hgene | IGF2R | P11717 | DB01277 | Mecasermin | Biotech | Approved|Investigational | |
| Hgene | IGF2R | P11717 | DB13173 | Cerliponase alfa | Ligand | Biotech | Approved|Investigational |
| Hgene | IGF2R | P11717 | DB13173 | Cerliponase alfa | Ligand | Biotech | Approved|Investigational |
Top |
Related Diseases for IGF2R-ACVR2A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | IGF2R | C0024115 | Lung diseases | 2 | CTD_human |
| Hgene | IGF2R | C0235833 | Congenital diaphragmatic hernia | 2 | CTD_human |
| Hgene | IGF2R | C0265699 | Congenital hernia of foramen of Morgagni | 2 | CTD_human |
| Hgene | IGF2R | C0265700 | Congenital hernia of foramen of Bochdalek | 2 | CTD_human |
| Hgene | IGF2R | C0002395 | Alzheimer's Disease | 1 | CTD_human |
| Hgene | IGF2R | C0011265 | Presenile dementia | 1 | CTD_human |
| Hgene | IGF2R | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | IGF2R | C0030567 | Parkinson Disease | 1 | CTD_human |
| Hgene | IGF2R | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | IGF2R | C0242973 | Ventricular Dysfunction | 1 | CTD_human |
| Hgene | IGF2R | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human |
| Hgene | IGF2R | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Hgene | IGF2R | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human |
| Hgene | IGF2R | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human |
| Hgene | IGF2R | C0553980 | Endomyocardial Fibrosis | 1 | CTD_human |
| Hgene | IGF2R | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human |
| Hgene | IGF2R | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human |
| Hgene | IGF2R | C0752347 | Lewy Body Disease | 1 | CTD_human |
| Hgene | IGF2R | C2239176 | Liver carcinoma | 1 | CGI;CTD_human |
| Tgene | ACVR2A | C0920269 | Microsatellite Instability | 1 | CTD_human |
| Tgene | ACVR2A | C1721098 | Replication Error Phenotype | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies